Fumarate Fesoterodine fumarate Fesoterodine
CAS 286930-03-8 MFCD12756004
化学结构图
SMILES: CC(C)C(=O)OC1C=CC(CO)=CC=1[C@@H](CCN(C(C)C)C(C)C)C1C=CC=CC=1.OC(=O)/C=C/C(O)=O |&1:14|
化学属性
| Mol. Formula | C30H41NO7 |
|---|---|
| Mol. Weight | 527.65 |
别名和识别编码
| Chemical Name | Fumarate Fesoterodine fumarate |
|---|---|
| CAS Number | 286930-03-8 |
| Synonym | 2-Methylpropanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl] |
| Chemical Name Translation | Fesoterodine |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Amines
- Aromatics
- Pharmaceuticals
- Intermediates & Fine Chemicals,
产品应用
- (R)-Fesoterodine Fumarate is a muscarinic receptor antagonist for the treatment of Lower Urininary Tract Symptoms (LUTS).
相关文献及参考
- [2]. Didem Yilmaz-Oral, et al. The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats.
- [3]. Peter Ney, et al. Pharmacological Characterization of a Novel Investigational Antimuscarinic Drug, Fesoterodine, in Vitro and in Vivo. BJU Int. 2008 Apr;101(8):1036-42.
- [4]. Martin C Michel, et al. Fesoterodine: A Novel Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder Syndrome. Expert Opin Pharmacother. 2008 Jul;9(10):1787-96.
- Rogers, D., et al.: Pharmacotherapy, 20, 1092 (2000),
- [1]. Ellsworth P, et al. Fesoterodine for the treatment of urinary incontinence and overactive bladder. Ther Clin Risk Manag. 2009;5:869-76. Epub 2009 Nov 18.
- [1]. Ellsworth P, et al. Fesoterodine for the treatment of urinary incontinence and overactive bladder. Ther Clin Risk Manag. 2009;5:869-76. Epub 2009 Nov 18.
- [2]. Didem Yilmaz-Oral, et al. T
